Horizon Discovery

Horizon Discovery is a revenue-generating life science group supplying research tools to organizations engaged in translational genomics research and the development of personalized medicines. Horizon has a diverse and international customer base of over 1,200 organizations across more than 50 countries, including major pharmaceutical, biotechnology and diagnostic companies as well as leading academic research centers. The Group supplies its products and services into multiple markets, estimated to total in excess of £29 billion by 2015.
Horizon’s core capabilities are built around its proprietary translational genomics platform, a high-precision and flexible suite of gene editing tools able to alter almost any endogenous gene sequence of human or mammalian cell-lines. Horizon offers over 20,000 catalogue products, almost all of which are based on the application of gene editing to generate cell lines that accurately model the disease-causing mutations found in genetically based diseases. These ‘patients-in-a-test-tube’ are being used by customers to identify the effect of individual or compound genetic mutations on drug activity, patient responsiveness, and resistance, which may lead to the successful prediction of which patient sub-groups will respond to currently available and future drug treatments. In addition, Horizon provides custom cell line and in vivo model generation services for research and bioproduction applications, quantitative molecular reference standards, in vivo disease models, and contract research and custom screening services.

Company growth
Type
Public
HQ
Waterbeach, GB
Founded
2005
Size (employees)
234 (est)+28%
Horizon Discovery was founded in 2005 and is headquartered in Waterbeach, GB

Key People at Horizon Discovery

Chris Claxton

Chris Claxton

VP, Marketing
Kyla Grimshaw

Kyla Grimshaw

R&D Director, Discovery Services
Kam Dhaliwal

Kam Dhaliwal

VP, Sales
Dan Cowell

Dan Cowell

VP, Operations
Ian Gilham

Ian Gilham

Interim Chairman
Simon Cook

Simon Cook

Non Executive Director

Horizon Discovery Office Locations

Horizon Discovery has offices in Waterbeach, Boyertown, St. Louis, Wien and in 1 other locations
Waterbeach, GB
Boyertown, US
St. Louis, US
Wien, AT
Cambridge, US

Horizon Discovery Metrics

Horizon Discovery Summary

Market capitalization

£159 M

Closing share price

£1.69
Horizon Discovery's current market capitalization is £159 M.

Horizon Discovery Financials

Horizon Discovery's revenue is £20.2 M in FY, 2015 which is 69.31% increase from the previous period.
FY, 2015FY, 2014FY, 2013

Revenue

£20.2 M£11.9 M£6.65 M

Revenue growth, %

69.3%79.1%

Cost of sales

£10.2 M£5.35 M£3.21 M

Gross profit

£9.96 M£6.55 M£3.44 M

Gross profit Margin, %

49.4%55.1%51.7%

Operating expense total

£20.3 M£12.7 M£6.37 M

Horizon Discovery Market Value History

Horizon Discovery Online Presence

Horizon Discovery News

Horizon Discovery Company Life

You may also be interested in